Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Timing of aspirin administration in hypertensive patients (TAHPS)
2011-004760-29Phase 3Completed
- Sponsor
- Maria Victoria Ruiz Arzalluz
- Start
- Nov 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of aspirin in hypertension (HTN) and cardiac morbidity (2 arms), sponsored by Maria Victoria Ruiz Arzalluz. Primary endpoints: 24-hour mean systolic blood pressure and 24-hour mean diastolic blood pressure. Started Nov 2011; status: completed.
02
Drugs
aspirin
03
Conditions
hypertension (HTN)cardiac morbidity
Beyond the preview
Go deeper on 2011-004760-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004760-29.